Tonghua Dongbao Pharmaceutical Co Ltd is a high-risk Pharmaceuticals company based in China. Specializing in the production and distribution of a variety of pharmaceutical products including human insulin injection, Heart and brain capsule, Vitamin e soft capsule, and Oral detoxification products. With an ESG score of 30.9, Tonghua Dongbao Pharmaceutical is committed to environmental sustainability and governance practices in the industry.